These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29982646)

  • 1. Frequency of Herpes Zoster Vaccination Among Inflammatory Bowel Disease Patients.
    Khan N; Trivedi C; Kavani H; Lewis J; Yang YX
    Inflamm Bowel Dis; 2019 Jan; 25(2):345-351. PubMed ID: 29982646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Live Attenuated Herpes Zoster Vaccine in Patients With Inflammatory Bowel Diseases.
    Khan N; Trivedi C; Kavani H; Medvedeva E; Lewis J; Yang YX
    Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1341-1347. PubMed ID: 30326303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes Zoster Infection and Herpes Zoster Vaccination in a Population-Based Sample of Persons With IBD: Is There Still an Unmet Need?
    Nugent Z; Singh H; Targownik LE; Bernstein CN
    Inflamm Bowel Dis; 2019 Feb; 25(3):532-540. PubMed ID: 30085137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of herpes zoster vaccination among inflammatory bowel disease patients being treated with anti-TNF medications.
    Khan N; Shah Y; Trivedi C; Lewis JD
    Aliment Pharmacol Ther; 2017 Oct; 46(7):668-672. PubMed ID: 28805309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study.
    Khan N; Patel D; Trivedi C; Shah Y; Lichtenstein G; Lewis J; Yang YX
    Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1919-1927.e3. PubMed ID: 29309905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The need for better preventative strategies for inflammatory bowel disease patients at risk of herpes zoster virus.
    Bye WA; Sparrow MP; Connor SJ; Andrews JM; Ellard K; Ng W; Hume G; Antoniades S; Walsh AJ
    Intern Med J; 2017 Nov; 47(11):1263-1269. PubMed ID: 28516725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes Zoster Incidence in Inflammatory Bowel Disease Patients: A Population-Based Study.
    Côté-Daigneault J; Bessissow T; Nicolae MV; Nie R; Bitton A; Lakatos PL; Brassard P
    Inflamm Bowel Dis; 2019 Apr; 25(5):914-918. PubMed ID: 30295818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Recombinant Zoster Vaccine in Patients With Inflammatory Bowel Disease.
    Khan N; Wang L; Trivedi C; Pernes T; Patel M; Xie D; Yang YX
    Clin Gastroenterol Hepatol; 2022 Jul; 20(7):1570-1578.e1. PubMed ID: 34274513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Severity of Herpes Zoster in Inflammatory Bowel Disease Patients Treated With Anti-TNF Agents.
    Khan N; Trivedi C; Shah Y; Patel D; Lewis J; Yang YX
    Inflamm Bowel Dis; 2018 May; 24(6):1274-1279. PubMed ID: 29522099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study.
    Zhang J; Delzell E; Xie F; Baddley JW; Spettell C; McMahan RM; Fernandes J; Chen L; Winthrop K; Curtis JR
    Arthritis Res Ther; 2011; 13(5):R174. PubMed ID: 22024532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases.
    Zhang J; Xie F; Delzell E; Chen L; Winthrop KL; Lewis JD; Saag KG; Baddley JW; Curtis JR
    JAMA; 2012 Jul; 308(1):43-9. PubMed ID: 22760290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Zoster Vaccine [RZV] is Effective in Patients with Inflammatory Bowel Disease: A US Propensity Matched Cohort Study.
    Desai A; Hashash JG; Kochhar GS; Hayney MS; Caldera F; Farraye FA
    J Crohns Colitis; 2024 Jun; 18(6):828-835. PubMed ID: 38224526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease.
    Long MD; Martin C; Sandler RS; Kappelman MD
    Aliment Pharmacol Ther; 2013 Feb; 37(4):420-9. PubMed ID: 23240738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease.
    Khan N; Trivedi C; Aberra F; Pernes T; Yang YX
    J Crohns Colitis; 2022 Sep; 16(9):1505-1507. PubMed ID: 35350070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older.
    Izurieta HS; Wernecke M; Kelman J; Wong S; Forshee R; Pratt D; Lu Y; Sun Q; Jankosky C; Krause P; Worrall C; MaCurdy T; Harpaz R
    Clin Infect Dis; 2017 Mar; 64(6):785-793. PubMed ID: 28362955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Risk of Herpes Zoster in Young and Metabolically Healthy Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study.
    Soh H; Chun J; Han K; Park S; Choi G; Kim J; Lee J; Im JP; Kim JS
    Gut Liver; 2019 May; 13(3):333-341. PubMed ID: 30602222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of recombinant zoster vaccine (RZV) in patients with inflammatory bowel disease.
    Kochhar GS; Desai A; Caldera DO F; El Hachem S; Aoun E; Sandhu D; Mohan BP; Dulai PS; Farraye FA
    Vaccine; 2021 Jul; 39(30):4199-4202. PubMed ID: 34140170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.
    Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY
    J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevaccination epidemiology of herpes zoster in Denmark: Quantification of occurrence and risk factors.
    Schmidt SAJ; Vestergaard M; Baggesen LM; Pedersen L; Schønheyder HC; Sørensen HT
    Vaccine; 2017 Oct; 35(42):5589-5596. PubMed ID: 28874322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and Prevention of Herpes Zoster in the Immunocompromised Inflammatory Bowel Disease Patient: A Clinical Quandary.
    Côté-Daigneault J; Peerani F; MacMahon E; Delaporte E; Rahier JF; Colombel JF
    Inflamm Bowel Dis; 2016 Oct; 22(10):2538-47. PubMed ID: 27598743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.